Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: A potential immunoregulatory role for CD8+ T cells

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 915-924

  Gurunathan, Sanjay ^a   Stobie, Laura ^a,d   Prussin, Calmin ^b   Sacks, David L ^b   Glaichenhaus, Nicolas ^c   Fowell, Deborah J ^e   Locksley, Richard M ^d,e   Chang, John T ^d   Wu, Chang You ^a   Seder, Robert A ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CNRS   (France)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; PROTEIN KINASE C; RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREGULATION; INFECTION CONTROL; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; VACCINATION;

EID: 0034661668     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.915     Document Type: Article

References (36)

1. Donnelly, J. J., S. B. Ulmer, J. W. Shiver, and M. A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617.
2. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
3. Liew, F. Y., C. Hale, and J. G. Howard. 1982. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. J. Immunol. 128:1917.
4. + T cells. Immunol. Cell Biol. 66:57.
5. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis: T-cell lines that transfer protective immunity or exacerbation belong to different T-helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675.
6. Locksley, R. M., S. L. Reiner, F. Hatam, D. R. Littman, and N. Killeen. 1993. Helper T-cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261:1448.
7. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567.
8. + T cells is sufficient to mediate T helper cell type 1 development. J. Exp. Med. 188:1651.
9. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541.
10. Launois, P., K. G. Swihart, G. Milon, and J. A. Louis. 1997. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158:3317.
11. Mougneau, E., F. Altare, A. E. Wakil, S. Zheng, T. Coppola, Z. E. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression and cloning of a protective Leishmania antigen. Science 268:563.
12. Julia, V., M. Rassoulzadegan, and N. Glaichenhaus. 1996. Resistance to Leishmania major induced by tolerance to a single antigen. Science 274:421.
13. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
14. Gurunathan, S., C. Prussin, D. L. Sacks, and R. A. Seder. 1998. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat. Med. 4:1409.
15. Gurunathan, S., D. L. Sacks, D. R. Brown, S. L. Reiner, H. Charest, N. Glaichenhaus, and R. A. Seder. 1997. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J. Exp. Med. 186:1137.
16. Parks, D. R., and L. A. Herzenberg. 1989. Flow cytometry and fluorescence-activated cell sorting. In Fundamental Immunology. 2nd Ed. W. E. Paul, ed. Raven Press, New York, p. 781.
17. Chang, J. T., E. M. Shevach, and B. M. Segal. 1999. Regulation of interleukin (IL)-12 receptor β2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cells. J. Exp. Med. 189:969.
18. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88:7011.
19. 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J. Immunol. 151:2077.
20. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
21. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T-helper type-1 immune response. J. Exp. Med. 177:1797.
22. Hayes, M. P., J. H. Wang, and M. A. Norcross. 1995. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood 86:646.
23. Ma, X. J., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. E. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med. 183:147.
24. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12Rβ2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817.
25. Chua, A. O., V. L. Wilkinson, D. H. Presky, and U. Gubler. 1995. Cloning and characterization of a mouse IL-12 receptor-β component. J. Immunol. 155:4286.
26. Wu, C. Y., J. Ferrante, M. K. Gately, and J. Magram. 1997. Characterization of IL-12 receptor β1 chain (IL-12Rβ1)-deficient mice: IL-12Rβ1 is an essential component of the function mouse IL-12 receptor. J. Immunol. 159:1658.
27. + T lymphocytes to mediate protective immunity against Leishmania. J. Exp. Med. 169:1819.
28. + T-cells. Infect. Immun. 61:3730.
29. + T cells. Int. Immunol. 3:587.
30. + cytotoxic T-cell responses. Eur. J. Immunol. 24: 2813.
31. + T cells are inducers and targets of nitric oxide produced by parasitized macrophages. Eur. J. Immunol. 24:746.
32. Guler, M. L., N. G. Jacobson, U. Gubler, and K. M. Murphy. 1997. T cell genetic background determines maintenance of IL-12 signaling: effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. J. Immunol. 159:1767.
33. Sato, Y., M. Roman, H., Tighe, D., Lee, M., Corr, M. D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352.
34. Sur, S., X. Zhang, D. F. Tough, and J. Sprent. 1998. Type I interferon-mediated stimulation of T cells by CpG DNA. J. Exp. Med. 188:2335.
35. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type 1 interferon in vivo. Science 272:1947.
36. Diefenbach, A., H. Schindler, N. Donhauser, E. Lorenz, T. Laskay, J. MacMicking, M. Rollinghoff, I. Gresser, and C. Bogdan. 1998. Type 1 interferon (IFN α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8:77.